PM360

FEBRUARY 1, 2024

The landscape is highly competitive with new prescription medications launching worldwide each year. According to a McKinsey report , a startling 40% of biopharma products fail to meet their sales forecasts within the initial two years, prompting a critical reassessment of strategies for product launches.

Biopharma 59

Biopharma Competition Prescription Marketing 59

Evolve Your Success

SEPTEMBER 12, 2023

Sales in the endovascular space is not just about products; it’s about saving lives one catheter at a time. Join us as we explore the pulse of endovascular med device sales and uncover the heart behind the profession. As always, we do our best to bring your guests who are doing things differently in the medical sales space.

Sales 59

Sales Medical Medical sales Doctors 59

pharmaphorum

OCTOBER 1, 2022

In a dramatic change in fortunes, Novartis has won a major victory in its bid to defend oral multiple sclerosis therapy Gilenya from early generic competition in the US. Sales in the first half of this year fell 19% to $1.16 Gilenya made revenues of $2.8

Competition 52

Competition Pharma Marketing Sales 52

Pharmaceutical Technology

MARCH 24, 2023

Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. The biosimilar market in the US may progress differently this time.

Competition 59

Competition Marketing FDA Physicians 59

Pharmaceutical Technology

JULY 21, 2022

Pharma giant AstraZeneca also plans to make its supply chain carbon-negative by 2030; to reduce its Scope 1 emissions by 20%, Scope 2 emissions by 95%, and Scope 3 emissions by 25% per $1m of sales by 2025. Access to medication. According to the World Health Organization (WHO), two billion people lack access to essential or basic drugs.

Government 52

Government Healthcare Healthcare Pharma 52

PM360

NOVEMBER 29, 2022

1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade. MSLs do not need another system designed for sales reps. The Right Stuff. They want a system that is right for them. The global pool of investigators is growing on average between 3.3-5.6%

Medical science 95

Medical science Medical Customer Relationship Management Doctors 95

Contrarian Sales Techniques

NOVEMBER 4, 2024

Chronology of Events Leading Up to Today Early Days and Meteoric Rise 2010: Fashion Valet was founded by Datin Vivy Yusof and Datuk Fadzaruddin Shah Anuar with a vision of becoming Malaysia’s leading fashion platform. Key Events Leading to the Sale Financial Strain : Fashion Valet struggled to secure additional funding to sustain operations.

Government 40

Government Competition Marketing Sales 40

PM360

NOVEMBER 21, 2024

He was Executive VP and President of Merck’s Global Human Health Division from 2010 to 2019. Prior to becoming President of Global Human Health, he served as President of Merck’s global pharmaceutical business from 2007 to 2010. In this role, he was also a member of Merck’s executive committee.

Ethics 59

Ethics Food and Drug Administration Marketing Healthcare 59

Healthcare Success

NOVEMBER 14, 2022

The Patient Protection and Affordable Care Act of 2010 has increased access to healthcare services for previously uninsured populations. A buyer persona is a semi-fictional representation of your ideal customer based on sales data and industry research. The more detailed you are, the better.

Medical 70

Medical Marketing Engineering Doctors 70

pharmaphorum

AUGUST 5, 2022

Through our recent report, Scientific innovations for more sustainable growth , we analysed over 300 M&A deals made by the world’s top 30 biopharma companies between 2010–2021. Collaboration across the industry is needed now more than ever before across this complex ecosystem – not least because it’s becoming a competitive landscape.

Biopharma 52

Biopharma Marketing Pharma Relationship management 52

Evolve Your Success

MAY 16, 2023

I have a big playlist of medical sales, medical information, news and innovation. While I was there, I met the hospice world, hospice sales and the ins and outs of hospice care. I remember back in my pharmaceutical sales rep days and I’m talking as far as 2009 or 2010. This is a whole new thing for you?

Medical sales 52

Medical sales Sales Medical Doctors 52

Pharmaceutical Technology

OCTOBER 28, 2022

It initially targeted seven serotypes, before Pfizer launched an updated version that targeted 13 serotypes in 2010. According to GlobalData, Pharmaceutical Technology’s parent company, Prevnar 13 and Vaxneuvance are forecasted to have global sales of $7.26 VAX-24 has forecasted sales of $21 million in the same year.

Training 64

Training Marketing Competition FDA 64

Contrarian Sales Techniques

FEBRUARY 26, 2023

There was an article that examine the market for generic medicines in the Malaysia, following the introduction of the first generic patent in 2010 and the introduction of generic patent law in 2012. This growth is reflected in improved public health and lower prices for consumers, as well as higher sales of generic medicines.

Pharmaceutical 52

Pharmaceutical Medicine Government Manufacturing 52

Healthcare Success

NOVEMBER 25, 2024

So there are those tasks as well but At the time when I go back to that sort of 2010 timeframe. Stewart Gandolf Oh, it's a sales thing. The old school way is, you have a sales force, and then you go send in a rep to go see a doctor. by hiring armies of sales, reps. and having sold my company and working on a PhD.

Healthcare 62

Healthcare Healthcare Doctors Physicians 62

Pharmaceutical Technology

MAY 29, 2008

PT: How do you think GSK is placed competitively? Important elements within this expectation are the build up of strong contributions from Rotarix, Cervarix and Tykerb, while the outlook for GSK’s important asthma franchise becomes less clear beyond 2010. PD: We believe that GSK has the strongest pipeline in the industry.

Pharmaceutical 40

Pharmaceutical Marketing Sales Prescription 40

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97